Trend Results : The Nasdaq


Related Searches

Blog Post Results (1-20 of 10000+)

FILTER RESULTS

4 Terrific Reasons To Invest In First Solar

By Anup Singh: Solar energy solutions provider First Solar (NASDAQ:FSLR) is on an outstanding run this year. The stock has already gained 12% so far in 2014, and it looks likely that its robust performance will continue going forward. Show More Summary

4 Terrific Reasons To Buy Groupon On The Pullback

By Anup Singh: Although shares of daily deals site Groupon (NASDAQ:GRPN) are down more than 45% in 2014, a closer look at the company's fundamentals, balance sheet, and terrific growth make it an enticing prospect. Groupon is posting rapid growth in revenue, and its user metrics are also growing at a robust pace. Show More Summary

3 Solid Reasons Why SolarCity Should Continue Growing

By Mitu Anand: Already the largest solar panel installer in the U.S., SolarCity (NASDAQ:SCTY) looks set to get better. Despite having a roller coaster ride in 2014, the stock is still up close to 15%, outperforming the S&P 500. Moreover,...Show More Summary

STOCKS ARE FALLING — DOW DOWN 100 (DIA, SPX, SPY, QQQ, IWM, HAS, HAL, AGN)

Stocks are lower, with the Dow down about 100 points as the market digests news from Gaza and Ukraine over the weekend. The S&P 500 is down 11 points, or 0.5%, and the Nasdaq is down 23 points, or 0.5%. President Obama is set to speak...Show More Summary

A Lot To Like In Stable Dividend Portfolio Pick Maiden Holdings

By Masterpiece Retirement Services: Maiden Holdings, Ltd. (NASDAQ:MHLD) is a Bermuda-based holding company, primarily focused on serving the needs of regional and specialty insurers in the United States and Europe by providing reinsurance solutions designed to support their capital needs. Show More Summary

Aquinox Pharmaceuticals: A Compelling Risk/Reward Ahead Of Data

By BiotechGuy: Background: Aquinox Pharmaceuticals (NASDAQ:AQXP), based in Vancouver, is developing a new, and potentially paradigm changing approach to treating inflammatory diseases and cancer. The company was founded in 2006 as aShow More Summary

Is Zynga A Buy On The Pullback?

By Renu Singh: The recruitment of Don Mattrick as Zynga (NASDAQ:ZNGA) CEO was supposed to turn around the company's prospects, but a look at the stock's performance so far this year indicates that not much has changed on the surface....Show More Summary

Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More?

ByDoctoRx: Background: When the Fed noted some froth in "smaller" biotechs last week, large ones also got slammed. Biogen Idec (NASDAQ:BIIB) fell more than 7% after that statement. Gilead Sciences (NASDAQ:GILD) fell 5% peak-to-trough. Show More Summary

Glu Mobile Poised To Climb 50% By Year-End

By Mark Gomes: Last Tuesday, we claimed that Glu Mobile's (NASDAQ:GLUU) Q3 revenue could DOUBLE the consensus view and raised our price target to $10. Seemingly incredulous, short-sellers called our report a "pump piece" and initiated...Show More Summary

Evaluating Biogen Idec After The Sell-Off

ByDoctoRx: Background: Biogen Idec (NASDAQ:BIIB) stock has taken a tumble following comments out of the Federal Reserve about smaller biotech stocks. The stock fell from over $320 to under $300 on no other news. This looks to me like...Show More Summary

Here's How Facebook Is Beating Google

By Renu Singh: Facebook (NASDAQ:FB) is on a terrific run in 2014. The social networking company's stock has already gained more than 27% this year, but there is no sign of a slowdown. Facebook is trying to be more than just a social network, it is trying to be one of the strongest advertisement networks as well. Show More Summary

Russian Hacking of Nasdaq: Further Color

Global risks on many fronts remain exceptionally elevated. From the Ukraine to a number of hot spots in the Middle East, to the South China Sea, to our southern border, global risk is rampant. Each of these situations entails real human suffering and generates strong reactions and appropriate empathy. Yet in the midst of […]

Short And Sweet: Microsoft Cuts 18,000 Jobs

By Valuentum: Quick and agile - that's what new Microsoft (NASDAQ:MSFT) memo to employees, the company revealed the largest layoffs in its corporate history, targeting the reduction of the size of its overall workforce by up to 18,000 jobs. Show More Summary

Update: GoPro Underwriters Release Reports

By Jeffrey Himelson: GoPro's (NASDAQ:GPRO) quiet period has come to an end this morning and the brokerage firms from the underwriting syndicate were allowed to release their reports. The reports were mixed, but in aggregate were positive. Show More Summary

Google: One Of The Best Values In This Overheated Market

By Valuentum: Google (NASDAQ:GOOG) (NASDAQ:GOOGL) is trading just shy of a market capitalization of $387 billion at the time of this writing, one of the largest US-traded stocks out there. For a company this big to grow revenue 22% in its second quarter, which it reported Thursday, is quite the feat. Show More Summary

5 More Possible Partners For MannKind's Afrezza, Each With A Strong Diabetes Care Franchise

ByPsycho Analyst: My previous article looked at the five largest global Big Pharma companies, ranked by revenues, to see if any of them might be the partner MannKind (NASDAQ:MNKD) needs to market and distribute its just-approved, novel, ultra-fast acting, inhaled insulin, Afrezza. Show More Summary

Citrix Killer: Sphere 3D's Debut On Nasdaq, Merger With Overland, Purchase Of V3 Systems

By Point Of Return: Sphere 3D Corp's (NASDAQ:ANY) debut on the NASDAQ Global Market this week heralds the arrival of a new and powerful competitor to the Information Storage and Virtualization sectors - two of the fastest growing segments of the world economy. Show More Summary

AbbVie Gets Its 'Tax Break' In Shire

By Suman Chatterjee: The pharmaceutical industry has constantly provided us with news of gigantic mergers lately. The current sensation is the purchase of Shire (NASDAQ: SHPG) by U.S. drug maker AbbVie (NYSE:ABBV) for $54 billion and establishing its tax HQ in the UK. Show More Summary

Apple's Transformation To Become A Dividend Stock Still In Progress

By Pim Keulen: By the end of last year, I wrote this article about Apple (NASDAQ:AAPL). I argued that Apple is just one year away from becoming a dividend stock instead of a growth stock. I based my arguments on the traditional business life cycle and several developments and events that occurred last year. Show More Summary

Trading the Earnings Parade: Apple Inc. (AAPL), Starbucks Corporation (SBUX) and the Boeing Company (BA)

Apple Inc. (NASDAQ:AAPL), Starbucks Corporation (NASDAQ:SBUX) and The Boeing Company (NYSE:BA) are some of the companies that are set to report their earning this week presenting some of the possible prospects for investing in the stock, either on the Short or Long positions. CNBC’s ‘Fast Money’ Trader, Timothy Seymour, has reiterated his long position on […]

Copyright © 2015 Regator, LLC